When was the last time you measured your waistline? If you assume that BMI is the only number to focus on when it comes to your health, think twice. New research has revealed a shocking revelation—your waist circumference might be a far better predictor of men's cancer risk than BMI.

The study finds that for each 4-inch increase in waist size, a man's risk of cancer increases by a staggering 25%. Meanwhile, BMI, commonly regarded as the gold standard for assessing obesity, raises cancer risk by only 19% for the same weight gain. So, if you've been dismissing that pesky belly fat, it's time to take notice.

But why is your waistline so important? The reason is visceral fat—the hidden, deep fat that accumulates around your organs. Unlike other body fat, visceral fat is a stealthy troublemaker, causing inflammation, insulin resistance, and abnormal blood fat levels—all of which combine to create a cancer-perfect storm.

Obesity has been associated with an increased risk of numerous health conditions, including cancer, for decades. The research, though, indicates that a specific measure of the body—waist circumference—may be an even more reliable forecaster of cancer risk in men than the more frequently employed Body Mass Index (BMI). This finding emphasizes the need to pay particular attention to the distribution of fat and not merely to the weight of the body.

BMI has been the go-to measure for years for gauging health risks related to obesity. New research, though, that appears in The Journal of the National Cancer Institute indicates that waist measurement is a better predictor of cancer risk in men. According to the research, four more inches (10 cm) around the waist will add 25% to a man's cancer risk. Conversely, a 3.7 kg/m² rise in BMI (from a BMI of 24 to 27.7) increased cancer risk by only 19%.

Why is waist circumference a better predictor, then? Unlike BMI, which measures weight relative to height, waist circumference actually measures abdominal fat—specifically, visceral fat. This type of fat encircles internal organs and is also linked to higher levels of inflammation, insulin resistance, and abnormal blood lipids, all of which are factors in cancer growth. BMI, however, does not measure fat distribution, so two individuals with the same BMI can have very different levels of health risk depending on where fat is deposited on their bodies.

Why Men Are at Higher Risk?

Interestingly, the research identified a significant difference between men and women when it came to waist circumference and cancer risk. Although waist circumference and BMI were linked with obesity-related cancers in women, the relationship was weaker than for men. An increase of 12 cm (4.7 inches) in waist size or a 4.3 rise in BMI (from 24 to 28.3) raised the cancer risk in women by just 13%—a much lower percentage than for men.

Experts credit this difference to the way that fat is stored in the body. Men are more likely to carry fat around the abdomen, especially as visceral fat, which is more metabolically active and associated with cancer-producing biological alterations. Women, by contrast, store fat in peripheral sites such as the hips and thighs, where it is less likely to drive systemic inflammation and metabolic disturbances.

A possible reason is that men tend to depot fat more in the visceral regions, whereas women tend to carry more subcutaneous and peripheral fat," wrote the researchers. "This may render waist circumference a more robust risk factor for cancer in men and account for why waist circumference provides additional risk information beyond BMI in men but not women."

Cancer Types Most Linked to Abdominal Fat

The research used the International Agency for Research on Cancer (IARC) data to define obesity-related cancers. These cancers are esophageal (adenocarcinoma), gastric (cardia), colorectal, rectal, liver, gallbladder, pancreatic, renal, and thyroid cancers, and multiple myeloma and meningioma. In men, abdominal obesity is especially significant in raising the risk of these cancers through high levels of insulin and markers of inflammation.

For women, the research proposes that both waist circumference and hip circumference may give a more accurate estimate of visceral fat and cancer risk. "Adding hip circumference to risk models could strengthen the link between waist circumference and cancer, especially in women," researchers observed.

What This Means for Men's Health and Cancer Prevention?

With these results, doctors advise men to be more mindful of their waistline than only their BMI. Waist size is an easy method to gauge health risk, and its maintenance through lifestyle changes might be the key to cancer prevention.

How To Reduce Cancer Risk In Men?

Track Your Waist Size: Regularly measure your waist circumference and try to keep it in a healthy range (below 40 inches for men, according to medical advice).

Eat a Balanced Diet: A diet containing high fiber, lean protein, and healthy fats can assist in limiting visceral fat gain.

Exercise Consistently: Regular exercise with a combination of aerobic and strength training will help maintain a healthy waistline.

Control Stress and Sleep: Persistent stress and inadequate sleep tend to cause weight gain, especially in the midsection of the body.

Regular Health Screenings: Early identification of cancer risk factors through regular screening can greatly enhance long-term health status.

Lung cancer is among one of the most feared health condition known to man and detecting it early on can make a difference between life and death but now a new study has even claiming of a more promising detection option where the detection the disease will be possible even before it starts to grow in this way the potential patient will be able to stay through screening and possible medication far before the ailment starts to grow in their body.

A new study by Australia’s Walter and Eliza Hall Institute of Medical Research (WEHI) has identified a new blood signature that might detect cancer even before the disease develops. They are claiming that with this blood test, there is a chance that detection can be possible even 5 years before it actually occurs. The study was published in Cell.

The research was conducted with over 48,000 blood samples, and they identified a 14-protein signature that predicted lung cancer risk within five years and was validated across eight international datasets. Researchers made clear that the detection did not come from the tumor but from a different inflammatory lung environment that precedes cancer.

WEHI laboratory head Clare Weeden, a corresponding author on the paper, said: "The study could lead to more inclusive and effective screening approaches for people in Australia and across the world." She added, “In doing so, these findings bring us closer to a future where early intervention is possible, even before the cancer has a chance to develop.”

Also Read: Diphtheria Outbreak: Australia Reports First Death In A Decade

What Is Lung Cancer?

Lung Cancer is one of the most common and serious types of cancer. It is also the leading cause of cancer-related deaths worldwide, with approximately 2.5 million new cases and 1.8 million deaths reported in 2022. According to the American Cancer Society, lung cancer mainly occurs in older people. Most people diagnosed with lung cancer are 65 or older; a very small number of people diagnosed are younger than 45.

The Two Main Types Of Lung Cancers Are:

Non-small-cell lung cancer (NSCLC): This is the most common form, making up about 80–85% of all cases. NSCLC includes three subtypes:

• Squamous cell carcinoma
• Adenocarcinoma
• Large-cell carcinoma

Small-cell lung cancer (SCLC): Less common than NSCLC, this type tends to grow and spread more quickly.

Early Signs And Symptoms To Look Out For

Lung cancer symptoms can mimic less serious conditions, which is why they’re often dismissed or misdiagnosed. If you experience the following symptoms persistently, don’t ignore them—regardless of your age or smoking history:

• Chest pain or discomfort
• Unexplained shortness of breath
• Persistent cough or wheezing
• Shoulder, back, or rib pain
• Fatigue or sudden weight loss
• Blood in sputum (though not always present).

For many young and middle- aged adults, headaches or brief dizzy spells often feel routine — attributed to long work hours, stress, or poor sleep. Occasional blackouts or “spacing out” episodes may be brushed aside as fatigue or skipped meals.

What makes these symptoms particularly dangerous is that they are often mistaken for burnout, stress, migraines, or exhaustion — especially among younger working professionals. While most headaches are harmless, persistent neurological symptoms that disrupt daily life should never be ignored.

But there are neurological symptoms you should never ignore: sudden seizures, memory loss after brief collapse, repeated headaches, unexplained weakness, or changes in personality. These can sometimes point to an underlying brain disorder — and, in rare cases, to Glioblastoma, one of the most aggressive forms of brain cancer.

Glioblastoma (GBM) is one of the most aggressive and fast-growing forms of brain cancer in adults. It develops in the supportive tissue of the brain and can quickly affect memory, speech, movement, personality, and other neurological functions. Because the tumour tends to spread into nearby healthy brain tissue, complete surgical removal is often difficult, making timely diagnosis and treatment extremely important. While brain tumours are often associated with older adults, specialists are increasingly seeing younger individuals dismiss early warning signs as work-related fatigue, lack of sleep, stress, or lifestyle burnout. Delayed recognition can sometimes postpone critical medical intervention. In India, there are around 23,000 glioblastoma cases per day, considered higher incidence rates along with North America, Australia, Northern and Eastern Europe. Seizures and persistent headaches are often among the earliest symptoms that prompt medical investigation.

Recently, a 34-year-old woman presented to Apollo Hospitals, Bannerghatta with seizures and memory loss. Her first seizure occurred one morning at home — she collapsed briefly, with twisting of arms and legs, and woke with total memory loss of the episode. Like many young professionals struggling between work and personal commitments, she first considered the cause to be work-induced stress. The family did not suspect that these seemingly routine headaches and blackouts could indicate a serious neurological condition. Before that, she had minor headaches — the kind most people ignore. An MRI scan revealed brain swelling, and anti-seizure medication was prescribed. A second opinion at month’s end showed swelling reduction.

The turning point came in late, during a road trip, when she suffered three seizures in two hours. A burr hole biopsy of a right frontal lesion suggested a diffuse low-grade glioma. Subsequent evaluations at Apollo Hospitals upgraded the diagnosis to bifrontal Glioblastoma — a clinically challenging case due to its location. This is a clinically unusual case because most of the time, GBM is diagnosed with MRI with contrast, MR spectroscopy, and biopsy to confirm the type and grade of tumor. In this patient’s case, imaging revealed widespread bifrontal involvement — making conventional surgery high risk. Her care team opted for a non-surgical precision radiotherapy approach. She had 25 high precision image guided radiotherapy (IGRT) sessions using RapidArc technology. This was followed by two CyberKnife boost sessions to high-risk tumour areas - a plan to boost treatment precisely where it was most needed. All sessions went smoothly, with no major side effects. Since October 2024, she has been undergoing her cycle of monthly chemotherapy treatment alongside her regular scanning.Happily, she was also able to slowly get back to work, engage in recreational activities, and gain a semblance of normal life despite the ongoing cancer treatment.

Signs that point to headaches along with seizures, vomiting, blurred vision, confusion, personality changes, weakness, or an increasing frequency of symptoms should be evaluated medically without delay. Even one seizure is not an issue to ignore.

Some symptoms you must mention to your doctor will be:

• Dizziness or headaches

• Constriction
• Trembling and weakness or paralysis
• Memory loss or other indications of memory disorder
• Visual difficulties

It may help you diagnose your problems effectively if you see a neurologist, conduct MRI brain imaging and have consultations from an early stage. While some headaches or seizures do not necessarily mean having a tumor in the brain, regular occurrence of such symptoms with no reason is likely to be examined by an expert. However, although a proper healthy lifestyle may help your brain remain healthy, it will be ineffective for illnesses like GBM.

Glomerular Diseases affect the glomeruli, which are very small filtering units in the human kidney, and when they get damaged due to disorders, the filters leak blood and vital proteins into the urine and fail to remove waste efficiently. Eventually, these problems can lead to chronic kidney disease or kidney failure. As per its treatment, medications are used to slow kidney damage, manage blood pressure, and reduce protein leakage.

Notably, a new study has revealed hope in this condition by finding that a well-known drug can be very effective in slowing damage if the patient has Glomerular Diseases, and that common drug is Finerenone, which is often prescribed for heart and kidney diseases associated with type 2 diabetes.

The trial was participated in by 903 participants with glomerular diseases. The drug finerenone was given to them. The results show that compared with placebo, it slowed kidney damage, reduced albuminuria, and lowered the risk of kidney failure or sustained loss of kidney function.

Thus, the study clearly indicates that the drug called finerenone may play an important role in protecting kidney function in patients with glomerular diseases.

The research was conducted through subgroup analysis of a phase 3, randomized, double-blind, placebo-controlled trial conducted across 24 countries and regions, focusing on participants with an investigator-reported glomerular disease.

The study was conducted on a large scale, having conducted the research for months in 24 countries and regions. The trial also took care of other important details and implemented all required paperwork, thus securing approvals by regulatory authorities along with ethics committees in every center. Other than that, the participants were required to submit written informed consent. Moreover, an independent data monitoring committee performed safety monitoring throughout the tests.

How To Keep Kidneys Healthy?

Dietary habits can contribute to kidney strain, particularly when busy schedules encourage reliance on convenient foods that are often high in sodium and low in nutritional value.

Hydration habits are additional concerns among office workers. Many professionals rely heavily on coffee, energy drinks, or sugary beverages during long workdays, often replacing plain water as the main source of fluid intake.

Protecting kidney health often begins with small lifestyle changes. Reducing processed food consumption, limiting excessive salt intake, staying adequately hydrated, and maintaining regular sleep schedules can all support kidney function.

Taking short movement breaks during long work hours and managing stress through regular physical activity or relaxation techniques may also help reduce the long-term strain that modern work routines place on the body.